Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Functional characterization of the biogenic amine transporters on human macrophages
Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei
Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei
View: Text | PDF
Research Article Inflammation Neuroscience

Functional characterization of the biogenic amine transporters on human macrophages

  • Text
  • PDF
Abstract

Monocyte-derived macrophages (MDMs) are key players in tissue homeostasis and diseases regulated by a variety of signaling molecules. Recent literature has highlighted the ability for biogenic amines to regulate macrophage functions, but the mechanisms governing biogenic amine signaling in and around immune cells remain nebulous. In the CNS, biogenic amine transporters are regarded as the master regulators of neurotransmitter signaling. While we and others have shown that macrophages express these transporters, relatively little is known of their function in these cells. To address these knowledge gaps, we investigated the function of norepinephrine transporter (NET) and dopamine transporter (DAT) on human MDMs. We found that both NET and DAT are present and can uptake substrate from the extracellular space at baseline. Not only was DAT expressed in cultured MDMs, but it was also detected in a subset of intestinal macrophages in situ. Surprisingly, we discovered a NET-independent, DAT-mediated immunomodulatory mechanism in response to LPS. LPS induced reverse transport of dopamine through DAT, engaging an autocrine/paracrine signaling loop that regulated the macrophage response. Removing this signaling loop enhanced the proinflammatory response to LPS. Our data introduce a potential role for DAT in the regulation of innate immunity.

Authors

Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei

×

Figure 3

NET and DAT on human macrophages can work in uptake mode.

Options: View larger image (or click on image) Download as PowerPoint
NET and DAT on human macrophages can work in uptake mode.
(A) Schematic ...
(A) Schematic of the experimental design employing various conditions to measure DAT- versus NET-specific IDT307 uptake. (B) Representative 40× images of human macrophages following perfusion with IDT307 under conditions in A. (C and E). Quantification of IDT307 uptake as fold change in fluorescence in the presence of nomifensine (C), desipramine (E), or both antagonists (gray trace). (D and F) The nonspecific values (gray trace) were subtracted to show fold increase in NET- or DAT-mediated IDT307 uptake. (G and H) Blockade of either NET or DAT significantly decreased IDT307 uptake (average slope: control versus DAT-specific [P < 0.0001], control versus NET-specific [P < 0.0001]; AUC: control versus DAT-specific [P < 0.0001], control versus NET-specific [P < 0.0001]), and the multiantagonist cocktail further decreased IDT uptake (average slope: all block versus DAT-specific [P < 0.0001], all block versus NET-isolated; AUC: all block versus DAT-isolated, all block versus NET-specific [P = 0.0016]). Images and data in B–H are from n = 88–294 cells/group from 3 independent experiments. Statistical analysis in G was by Kruskal-Wallis test with Dunn’s test for multiple comparisons. Statistical analysis in H was by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparison’s test. (I) Nomifensine-sensitive uptake of tritiated dopamine (3H-DA) by cultured human macrophages shown as nM/min with a KM of approximately 3.2 μM. Data from 4 experiments from 2 donors. (J) Representative traces of inward currents on human macrophages measured via whole-cell voltage-clamp with vehicle, after amphetamine (AMPH), and after nomifensine, a DAT antagonist. The bath solution contained NET and SERT antagonists. (K) The DAT-mediated inward currents were calculated by subtracting the nomifensine current from the current in the no drug recording (baseline) or amphetamine recording (AMPH). (L) Bar graph compares basal and amphetamine-induced DAT-mediated inward current at –120mV (right, P = 0.01, Mann-Whitney U test). Data are from 9 experiments/group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts